But a new genetic test appears capable of sussing out which men are at greater risk of urinary side effects from radiation ...

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells ...

Breakthrough for bladder cancer patients as tablet treatment rolled out on NHS - Hundreds will benefit after the first ...

AstraZeneca (NASDAQ:AZN) has reached a significant milestone with the U.S. approval of its drug Imfinzi for adult patients with muscle-invasive bladder cancer. This approval marks a notable ...

Army bomb disposal veterans may have a significantly increased risk of developing bladder cancer compared to the general public, according to a newly published study. A research letter published ...

Cretostimogene monotherapy achieves a 75.5% complete response rate in high-risk, BCG-unresponsive non-muscle invasive bladder cancer patients. The treatment maintains a 46% complete response at 12 ...

Army bomb disposal veterans may have a significantly increased risk of developing bladder cancer compared to the general public, according to a newly published study. A research letter published in ...